[BRUSSELS] Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its US$62-billion bid for London's Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday. Read more at The Business Times.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Takeda sets vote date, aims to close US$62 billion Shire deal Jan. 8Japan's Takeda Pharmaceutical will hold an investor vote on its US$62 billion acquisition of Shire next month and aims to close the deal on Jan.
Read more »
Takeda CEO confident of investor backing for US$62 billion Shire dealThe boss of Japan's Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its US$62 billion acquisition of ...
Read more »
Takeda shareholders approve Shire acquisition: spokesmanTakeda Pharmaceutical shareholders approved on Wednesday its US$59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a ...
Read more »
Takeda shareholders give nod for US$59 billion Shire acquisitionTakeda Pharmaceutical shareholders approved on Wednesday its US$59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a ...
Read more »
Takeda pushes back as dissident shareholders seek to stop deal[LONDON] Takeda Pharmaceutical Co. chief executive officer Christophe Weber pushed back against dissident shareholders seeking to stop the Japanese drugmaker's acquisition of Shire Plc, saying he won't release minutes of boardroom discussions. Read more at The Business Times.
Read more »
Swiss risk EU anger after dodging EU treaty deadlineZURICH/BRUSSELS (REUTERS) - The Swiss government will consult domestic power brokers on a draft treaty setting out ties with the European Union, it said on Friday (Dec 7), ignoring an ultimatum from Switzerland's biggest trading partner to sign off now or face punishment.. Read more at straitstimes.com.
Read more »